Method validation and monitoring of emamectin benzoate in mature banana fruit with peel and pulp through Liquid chromatography-Mass spectrometry/ Mass spectrometry (LC-MS/MS)

Emamectin benzoate has been frequently used in the banana ecosystem to combat the damage of pseudostem weevil. Therefore, the present study was conducted to validate the method, to assess harvest time residues and monitor emamectin benzoate residues in mature banana peel and pulp samples through LC-MS/MS. The validated method was used to determine emamectin benzoate residue in market banana samples. The study used Waters Alliance LC and Acquity TQD with an electrospray ionization interface in the positive ion mode. An isocratic flow of 0.1% formic acid (HCOOH) in water and 0.1% HCOOH in acetonitrile (CH3CN) was utilised for separation. CH3CN was utilised to extract emamectin benzoate residue from the samples, and a dispersive solid-phase extraction technique was used for subsequent cleanup. Linearity tests were performed with standard solutions containing 0.01 to 0.1 g mL-1, with three replicates for each concentration. For mature banana peel & pulp and mature banana pulp matrices, satisfactory recoveries of 79.85 to 95.09% and 89.20 to 100.94%, respectively and high precision relative standard deviations of 0.56 to 2.34% and 2.33 to 6.88%, respectively were obtained. For mature banana (peel and pulp, pulp alone) fruits, the lower detection and quantification limits were (0.003, 0.008), and (0.002, 0.007). The validated approach was utilised to analyse mature banana fruit samples obtained from emamectin benzoate treated fields and banana samples purchased from the local market.  Results showed satisfactory validation of parameters like linearity, the limit of detection and quantification, and recovery for determining emamectin benzoate residues in banana fruit

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

Cast nephropathy is the most common cause of renal disease in multiple myeloma, however, treatment with plasma exchange remains controversial even after 3 randomized controlled studies. We sought to determine the importance of diagnostic confirmation and goal directed therapy in the treatment of cast nephropathy in forty patients with confirmed multiple myeloma and renal failure who underwent plasma exchange. A positive renal response was defined as a decrease by half in the presenting serum creatinine and dialysis independence. No baseline differences were noted between eventual renal responders and non-responders. Three quarters of the patients with biopsy proven cast nephropathy resolved their renal disease when the free light chains present in the serum were reduced by half or more but there was no significant response when the reduction was less. The median time to a response was about 2 months. In patients without cast nephropathy, renal recovery occurred despite reductions in free light chain levels of the serum. No association was found between free light chains in the serum, urinary monoclonal proteins, overall proteinuria and cast nephropathy. We found that the relationship between renal recovery and free light chain reduction was present only in patients with biopsy proven cast nephropathy showing the importance of extracorporeal light chain removal in this disease

High-temperature quantum oscillations caused by recurring Bloch states in graphene superlattices

Cyclotron motion of charge carriers in metals and semiconductors leads to Landau quantization and magneto-oscillatory behavior in their properties. Cryogenic temperatures are usually required to observe these oscillations. We show that graphene superlattices support a different type of quantum oscillations that do not rely on Landau quantization. The oscillations are extremely robust and persist well above room temperature in magnetic fields of only a few T. We attribute this phenomenon to repetitive changes in the electronic structure of superlattices such that charge carriers experience effectively no magnetic field at simple fractions of the flux quantum per superlattice unit cell. Our work points at unexplored physics in Hofstadter butterfly systems at high temperatures

c-Axis Transport and Resistivity Anisotropy of Lightly- to Moderately-Doped La_{2-x}Sr_{x}CuO_{4} Single Crystals: Implications on the Charge Transport Mechanism

Both the in-plane and the out-of-plane resistivities (\rho_{ab} and \rho_{c}) are measured in high-quality La_{2-x}Sr_{x}CuO_{4} (LSCO) single crystals in the lightly- to moderately-doped region, x = 0.01 to 0.10, and the resistivity anisotropy is determined. In all the samples studied, the anisotropy ratio \rho _{c}/\rho_{ab} quickly increases with decreasing temperature, although in non-superconducting samples the strong localization effect causes \rho _{c}/\rho_{ab} to decrease at low temperatures. Most notably, it is found that \rho_{c}/\rho_{ab} at moderate temperatures (100 - 300 K) is almost completely independent of doping in the non-superconducting regime (x = 0.01 to 0.05); this indicates that the same charge confinement mechanism that renormalizes the c-axis hopping rate is at work down to x = 0.01. It is discussed that this striking x-independence of \rho_{c}/\rho_{ab} is consistent with the idea that holes form a self-organized network of hole-rich regions, which also explains the unusually metallic in-plane transport of the holes in the lightly-doped region. Furthermore, the data for x > 0.05 suggest that the emergence of the superconductivity is related to an increase in the c-axis coupling.Comment: 7 pages, 5 figures, submitted to Phys. Rev.

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma

Extensive interindividual variation in response to chemotherapy is a major stumbling block in achieving desirable efficacy in the treatment of cancers, including multiple myeloma (MM). In this study, our goal was to develop a gene expression signature that predicts response specific to proteasome inhibitor (PI) treatment in MM. Using a well-characterized panel of human myeloma cell lines (HMCLs) representing the biological and genetic heterogeneity of MM, we created an in vitro chemosensitivity profile in response to treatment with the four PIs bortezomib, carfilzomib, ixazomib and oprozomib as single agents. Gene expression profiling was performed using next-generation high-throughput RNA-sequencing. Applying machine learning-based computational approaches including the supervised ensemble learning methods Random forest and Random survival forest, we identified a 42-gene expression signature that could not only distinguish good and poor PI response in the HMCL panel, but could also be successfully applied to four different clinical data sets on MM patients undergoing PI-based chemotherapy to distinguish between extraordinary (good and poor) outcomes. Our results demonstrate the use of in vitro modeling and machine learning-based approaches to establish predictive biomarkers of response and resistance to drugs that may serve to better direct myeloma patient treatment options

Viability of Noether symmetry of F(R) theory of gravity

Canonization of F(R) theory of gravity to explore Noether symmetry is performed treating R - 6(\frac{\ddot a}{a} + \frac{\dot a^2}{a^2} + \frac{k}{a^2}) = 0 as a constraint of the theory in Robertson-Walker space-time, which implies that R is taken as an auxiliary variable. Although it yields correct field equations, Noether symmetry does not allow linear term in the action, and as such does not produce a viable cosmological model. Here, we show that this technique of exploring Noether symmetry does not allow even a non-linear form of F(R), if the configuration space is enlarged by including a scalar field in addition, or taking anisotropic models into account. Surprisingly enough, it does not reproduce the symmetry that already exists in the literature (A. K. Sanyal, B. Modak, C. Rubano and E. Piedipalumbo, Gen.Relativ.Grav.37, 407 (2005), arXiv:astro-ph/0310610) for scalar tensor theory of gravity in the presence of R^2 term. Thus, R can not be treated as an auxiliary variable and hence Noether symmetry of arbitrary form of F(R) theory of gravity remains obscure. However, there exists in general, a conserved current for F(R) theory of gravity in the presence of a non-minimally coupled scalar-tensor theory (A. K. Sanyal, Phys.Lett.B624, 81 (2005), arXiv:hep-th/0504021 and Mod.Phys.Lett.A25, 2667 (2010), arXiv:0910.2385 [astro-ph.CO]). Here, we briefly expatiate the non-Noether conserved current and cite an example to reveal its importance in finding cosmological solution for such an action, taking F(R) \propto R^{3/2}.Comment: 16 pages, 1 figure. appears in Int J Theoretical Phys (2012

Intercalibration of the barrel electromagnetic calorimeter of the CMS experiment at start-up

Calibration of the relative response of the individual channels of the barrel electromagnetic calorimeter of the CMS detector was accomplished, before installation, with cosmic ray muons and test beams. One fourth of the calorimeter was exposed to a beam of high energy electrons and the relative calibration of the channels, the intercalibration, was found to be reproducible to a precision of about 0.3%. Additionally, data were collected with cosmic rays for the entire ECAL barrel during the commissioning phase. By comparing the intercalibration constants obtained with the electron beam data with those from the cosmic ray data, it is demonstrated that the latter provide an intercalibration precision of 1.5% over most of the barrel ECAL. The best intercalibration precision is expected to come from the analysis of events collected in situ during the LHC operation. Using data collected with both electrons and pion beams, several aspects of the intercalibration procedures based on electrons or neutral pions were investigated

Search for a W' boson decaying to a bottom quark and a top quark in pp collisions at sqrt(s) = 7 TeV

Results are presented from a search for a W' boson using a dataset corresponding to 5.0 inverse femtobarns of integrated luminosity collected during 2011 by the CMS experiment at the LHC in pp collisions at sqrt(s)=7 TeV. The W' boson is modeled as a heavy W boson, but different scenarios for the couplings to fermions are considered, involving both left-handed and right-handed chiral projections of the fermions, as well as an arbitrary mixture of the two. The search is performed in the decay channel W' to t b, leading to a final state signature with a single lepton (e, mu), missing transverse energy, and jets, at least one of which is tagged as a b-jet. A W' boson that couples to fermions with the same coupling constant as the W, but to the right-handed rather than left-handed chiral projections, is excluded for masses below 1.85 TeV at the 95% confidence level. For the first time using LHC data, constraints on the W' gauge coupling for a set of left- and right-handed coupling combinations have been placed. These results represent a significant improvement over previously published limits.Comment: Submitted to Physics Letters B. Replaced with version publishe

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project

Purpose: multiple myeloma is considered an incurable hematologic cancer but a subset of patients can achieve long-term remissions and survival. The present study examines the clinical features of long-term survival as it correlates to depth of disease response. Patients & Methods: this was a multi-institutional, international, retrospective analysis of high-dose melphalan-autologous stem cell transplant (HDM-ASCT) eligible MM patients included in clinical trials. Clinical variable and survival data were collected from 7291 MM patients from Czech Republic, France, Germany, Italy, Korea, Spain, the Nordic Myeloma Study Group and the United States. Kaplan–Meier curves were used to assess progression-free survival (PFS) and overall survival (OS). Relative survival (RS) and statistical cure fractions (CF) were computed for all patients with available data. Results: achieving CR at 1 year was associated with superior PFS (median PFS 3.3 years vs. 2.6 years, p < 0.0001) as well as OS (median OS 8.5 years vs. 6.3 years, p < 0.0001). Clinical variables at diagnosis associated with 5-year survival and 10-year survival were compared with those associated with 2-year death. In multivariate analysis, age over 65 years (OR 1.87, p = 0.002), IgA Isotype (OR 1.53, p = 0.004), low albumin < 3.5 g/dL (OR = 1.36, p = 0.023), elevated beta 2 microglobulin ≥ 3.5 mg/dL (OR 1.86, p < 0.001), serum creatinine levels ≥ 2 mg/dL (OR 1.77, p = 0.005), hemoglobin levels < 10 g/dL (OR 1.55, p = 0.003), and platelet count < 150k/μL (OR 2.26, p < 0.001) appeared to be negatively associated with 10-year survival. The relative survival for the cohort was ~0.9, and the statistical cure fraction was 14.3%. Conclusions: these data identify CR as an important predictor of long-term survival for HDM-ASCT eligible MM patients. They also identify clinical variables reflective of higher disease burden as poor prognostic markers for long-term survival